Researchers writing in Diabetes Care this month report that empagliflozin, a sodium–glucose cotransporter 2 inhibitor (SGLT2), successfully reduced liver fat content in recent-onset and metabolically well-controlled type 2 diabetes (T2D).
Endocrinology Network Editorial Staff
Leading experts on nutrition and diabetes are recommending that patients still continue to follow current nutritional recommendations by the American Diabetes Association and other healthcare and governmental organizations that recommend consuming a diet rich in fruits and vegetables, while limiting red and processed meats.
The FDA announced yesterday that it has approved the first treatment for thyroid eye disease: teprotumumab-trbw (Tepezza, Horizon Therapeutics).
The evidence is inconclusive, but a cross-sectional study of young men finds that omega−3 fatty acid supplements may improve semen quality and reproductive hormone levels in men.
A 38-year-old woman went to the doctor with several complaints that seemed unrelated but they had started within the last few months. She was feeling depressed and fatigued with tingling and numbness in her hands and feet. Can you diagnose this patient?
The U.S. Food and Drug Administration has approved an omega-3 fatty acid treatment as an add-on treatment to statin therapy to reduce the risk of cardiovascular disease in adults with elevated triglyceride levels.
Insulin resistance is independently associated with body mass index (BMI) and synovitis in rheumatoid arthritis patients, shows new research published in Arthritis and Rheumatology.
A mother brought her 7-year-old boy to the eye doctor after he complained for several months about increasing photophobia during outdoor activities like soccer practice and playground outings. She also noticed that he had been thirstier than usual during his soccer games, but wasn’t sweating as much as he usually did. During the slit lamp exam, the doctor noted crystals throughout his cornea and conjunctiva. What's your diagnosis?
In this slideshow, we review 10 new drugs or new indications for diabetes and other endocrine conditions.
A JAMA study finds that treating elderly patients who have subclinical hypothyroidism does not improve hypothyroid symptoms or fatigue.